Atorvastatin on Inflammatory Markers of the Patients Undergoing Precutaneous Coronary Intervention

Basic & Clinical Medicine ›› 2009, Vol. 29 ›› Issue (5): 549-550.

• 研究短文 • Previous Articles Next Articles

Atorvastatin on Inflammatory Markers of the Patients Undergoing Precutaneous Coronary Intervention

Jian-bing WANG, Yu-ming HAO, Dong-ying WANG, Rong-hong LIU, Hui SHAO, Yu-ling CUI

HuaBei Oil Hospital

Received:2008-05-29 Revised:2008-07-31 Online:2009-05-25 Published:2009-05-25
Contact: Jian-bing WANG,

Abstract

Jian-bing WANG; Yu-ming HAO; Dong-ying WANG; Rong-hong LIU; Hui SHAO; Yu-ling CUI. Atorvastatin on Inflammatory Markers of the Patients Undergoing Precutaneous Coronary Intervention[J]. Basic & Clinical Medicine, 2009, 29(5): 549-550.

[1]	Yong-hong CHEN; Song YANG; Jian-zhong ZHOU. Atorvastatin Alleviating Vascular Remodeling of Renal Hypertensive Rat [J]. Basic & Clinical Medicine, 2010, 30(4): 383-388.
[2]	Lu-qing WEI; Bin LIU; Zhen-hua LI; Wen-juan GUO. Atorvastatin alleviates pulmonary fibrosis-induced by bleomycin in rats [J]. Basic & Clinical Medicine, 2009, 29(11): 1198-1202.

Atorvastatin on Inflammatory Markers of the Patients Undergoing Precutaneous Coronary Intervention

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 2

Recommended Articles

Metrics

Comments